The attoworld-team warmly welcomes Min Kim. Min earned a PhD in Translational Research from King’s College London (2018). He then held postdoctoral and principal investigator roles in Denmark and the UK, applying multi-omics to map dysregulated pathways in fatty liver disease and Alzheimer’s disease. Recently, he has integrated microbiome, proteomic, and metabolomic profiling to enable early disease detection within precision medicine.
In the attoworld-team he will leverage his analytical and data science expertise to develop a cutting-edge diagnostic tool, pushing the boundaries of preventive medicine by identifying diseases at their earliest stages.
Picture: Thorsten Naeser
